Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Merrill

Showing results (71-80 of 414) with videos related to

Pageof 42
Sort By:
Retinal Cases & Brief Reports|September 19, 2015
SPOTTED FEVER GROUP RICKETTSIA RETINITIS IN A TRAVELER TO AFRICARenaud Duval, Pauline T Merrill
Science (New York, N.Y.)|April 23, 2005
A lupus drug and FDA approvalJoan T Merrill, Sandra Raymond
Expert Review of Clinical Immunology|May 19, 2010
Mycophenolate mofetil for lupus nephritisEwa Olech, Joan T Merrill
Nature Reviews. Rheumatology|October 9, 2013
Treatment of systemic lupus erythematosus: new therapeutic avenues and blind alleysAikaterini Thanou, Joan T Merrill
Current Rheumatology Reports|April 23, 2013
Top 10 things to know about lupus activity measuresAikaterini Thanou, Joan T Merrill
The Journal of Computed Tomography|March 1, 1978
Computed tomography: planning, programming, budgetingR L Schapiro, T Merrill
Arthritis and Rheumatism|May 28, 2010
Rituximab: wanted dead or aliveJoan T Merrill, Jill P Buyon
Lupus|February 1, 1996
The antiphospholipid syndrome and SLE: is there a clue in the link between complement and coagulation?J T Merrill, R G Lahita
Nature Clinical Practice. Rheumatology|August 26, 2006
Catastrophic antiphospholipid syndromeJoan T Merrill, Ronald A Asherson
Nature Medicine|October 10, 2025
Developing cell therapies for lupusJoan T Merrill, Judith A James
Pageof 42

Showing results (71-80 of 414) with videos related to

Sort By:
Pageof 42
Retinal Cases & Brief Reports|September 19, 2015
SPOTTED FEVER GROUP RICKETTSIA RETINITIS IN A TRAVELER TO AFRICARenaud Duval, Pauline T Merrill
Science (New York, N.Y.)|April 23, 2005
A lupus drug and FDA approvalJoan T Merrill, Sandra Raymond
Expert Review of Clinical Immunology|May 19, 2010
Mycophenolate mofetil for lupus nephritisEwa Olech, Joan T Merrill
Nature Reviews. Rheumatology|October 9, 2013
Treatment of systemic lupus erythematosus: new therapeutic avenues and blind alleysAikaterini Thanou, Joan T Merrill
Current Rheumatology Reports|April 23, 2013
Top 10 things to know about lupus activity measuresAikaterini Thanou, Joan T Merrill
The Journal of Computed Tomography|March 1, 1978
Computed tomography: planning, programming, budgetingR L Schapiro, T Merrill
Arthritis and Rheumatism|May 28, 2010
Rituximab: wanted dead or aliveJoan T Merrill, Jill P Buyon
Lupus|February 1, 1996
The antiphospholipid syndrome and SLE: is there a clue in the link between complement and coagulation?J T Merrill, R G Lahita
Nature Clinical Practice. Rheumatology|August 26, 2006
Catastrophic antiphospholipid syndromeJoan T Merrill, Ronald A Asherson
Nature Medicine|October 10, 2025
Developing cell therapies for lupusJoan T Merrill, Judith A James
Pageof 42